120 related articles for article (PubMed ID: 6881415)
21. Prognostic significance of the tumor antigen TA-4 in squamous cell carcinoma of the uterine cervix.
Kato H; Morioka H; Aramaki S; Tamai K; Torigoe T
Am J Obstet Gynecol; 1983 Feb; 145(3):350-4. PubMed ID: 6824024
[TBL] [Abstract][Full Text] [Related]
22. Assessment of the mechanism of the leukocyte adherence inhibition test.
Tong AW; Burger DR; Finke P; Barney C; Vandenbark AA; Vetto RM
Cancer Res; 1979 Feb; 39(2 Pt 2):597-603. PubMed ID: 367586
[TBL] [Abstract][Full Text] [Related]
23. Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma.
Kato H; Torigoe T
Cancer; 1977 Oct; 40(4):1621-8. PubMed ID: 332328
[TBL] [Abstract][Full Text] [Related]
24. Bovine ocular squamous cell carcinoma: tumor-associated immunity detected by E-rosette augmentation test.
Kuchroo VK; Jennings PA; Spradbrow PB
J Natl Cancer Inst; 1983 Feb; 70(2):305-9. PubMed ID: 6600505
[TBL] [Abstract][Full Text] [Related]
25. [Studies on tumor-specific immune response evaluated by leucocyte migration inhibition test under agarose-plate in gynecological malignancy (author's transl)].
Nakamura S
Acta Obstet Gynaecol Jpn; 1981 Jul; 33(7):1015-24. PubMed ID: 6171133
[TBL] [Abstract][Full Text] [Related]
26. Immunological response of patients with tumors of the urogenital tract: a follow-up of cell-mediated antitumor immunity by the LAI test.
Holán V; Heyberger K; Bubeník J; Hasek M; Kanka J; Laurová L
Neoplasma; 1977; 24(1):71-9. PubMed ID: 320490
[TBL] [Abstract][Full Text] [Related]
27. [Significance and implication on changes of serum squamous cell carcinoma antigen in the diagnosis of recurrence squamous cell carcinoma of cervix].
Li Q; Liu S; Liu H; Zhang J; Guo S; Wang L
Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):131-6. PubMed ID: 25877611
[TBL] [Abstract][Full Text] [Related]
28. Bovine ocular squamous-cell carcinoma: lymphocyte response to phytohaemagglutinin and tumour antigen.
Jennings PA; Lavin MF; Hughes DJ; Spradbrow PB
Br J Cancer; 1979 Oct; 40(4):608-14. PubMed ID: 497111
[TBL] [Abstract][Full Text] [Related]
29. The impact of squamous cell carcinoma (SCC) antigen in patients with advanced cancer of uterine cervix treated with (chemo-)radiotherapy.
Micke O; Bruns F; Schäfer U; Prott FJ; Willich N
Anticancer Res; 2005; 25(3A):1663-6. PubMed ID: 16033078
[TBL] [Abstract][Full Text] [Related]
30. Leucocyte adherence inhibition assay for cell-mediated immunity and immunodiagnosis of pancreatic cancer.
Onji M
Gastroenterol Jpn; 1984 Aug; 19(4):328-35. PubMed ID: 6333369
[TBL] [Abstract][Full Text] [Related]
31. Cellular immunity as a host response to squamous carcinoma of the cervix.
Goldstein MS; Shore B; Gusberg SB
Am J Obstet Gynecol; 1971 Nov; 111(6):751-5. PubMed ID: 5166388
[No Abstract] [Full Text] [Related]
32. [Cellular immunity in carcinoma of the uterine cervix].
Pasqualini RS; Giraudo Conesa LC; Chevallier R
Medicina (B Aires); 1981; 41 Suppl():155-60. PubMed ID: 7345340
[No Abstract] [Full Text] [Related]
33. Radioisotopic 51Cr-leukocyte adherence inhibition (LAI) assay. I. Demonstration of anti-tumor immunity in patients with breast carcinoma.
Tsang PH; Tangnavarad K; Lesnick G; Perloff M; Holland JF; Bekesi JG
J Immunol Methods; 1980; 36(2):119-35. PubMed ID: 7000908
[TBL] [Abstract][Full Text] [Related]
34. Changes in tumor immunity during therapy determined by leukocyte adherence inhibition and dermal testing.
Vetto RM; Burger DR; Vandenbark AA; Finke PE
Cancer; 1978 Mar; 41(3):1034-9. PubMed ID: 346188
[TBL] [Abstract][Full Text] [Related]
35. An overview: antitumor immunity in breast cancer assayed by tube leukocyte adherence inhibition.
Flores M; Marti JH; Grosser N; MacFarlane JK; Thomson DM
Cancer; 1977 Feb; 39(2):494-505. PubMed ID: 319891
[TBL] [Abstract][Full Text] [Related]
36. Cell-mediated immunity in patients with cervical cancer.
Cerni C; Tatra G; Berger R; Micksche M
Oncology; 1979; 36(4):164-70. PubMed ID: 224356
[TBL] [Abstract][Full Text] [Related]
37. Delayed cutaneous hypersensitivity reactions to membrane extracts of carcinomatous cells of the cervix uteri.
Wells SA; Melewicz FC; Christiansen C; Ketcham AS
Surg Gynecol Obstet; 1973 May; 136(5):717-20. PubMed ID: 4701902
[No Abstract] [Full Text] [Related]
38. In vivo and in vitro measurements of the relationship of human squamous carcinomas to herpes simplex virus tumor-associated antigens.
Hollinshead AC; Chretien PB; Lee OB; Tarpley JL; Kerney SE; Silverman NA; Alexander JC
Cancer Res; 1976 Feb; 36(2 pt 2):821-8. PubMed ID: 56226
[TBL] [Abstract][Full Text] [Related]
39. Selective inhibition of leukocyte adherence in women with breast cancer using a variety of tissue extracts.
Fritze D; Kaufmann M; Drings P; Fedra G
Oncology; 1978; 35(6):242-5. PubMed ID: 370704
[TBL] [Abstract][Full Text] [Related]
40. Squamous cell carcinoma antigen: clinical utility in squamous cell carcinoma of the uterine cervix.
Bolli JA; Doering DL; Bosscher JR; Day TG; Rao CV; Owens K; Kelly B; Goldsmith J
Gynecol Oncol; 1994 Nov; 55(2):169-73. PubMed ID: 7959279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]